Dose-intense paclitaxel, etoposide and cyclophosphamide: a safe and active regimen for tumor cytoreduction and stem cell mobilization in metastatic breast cancer
- 1 January 2000
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 25 (2) , 123-130
- https://doi.org/10.1038/sj.bmt.1702125
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America.Journal of Clinical Oncology, 1997
- Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factor.Journal of Clinical Oncology, 1997
- Peripheral blood progenitor cells for marrow reconstitution: mobilization and collection strategiesTransfusion, 1996
- High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial.Journal of Clinical Oncology, 1995
- Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer.Journal of Clinical Oncology, 1995
- Peripheral blood expansion of early progenitor cells after high-dose cyclophosphamide and rhGM-CSFEuropean Journal of Cancer and Clinical Oncology, 1991
- Blood-derived haematopoietic cell transplants: blood to blood?The Lancet, 1991
- High levels of circulating haemopoietic stem cells in very early remission from acute non‐lymphoblastic leukaemia and their collection and cryopreservationBritish Journal of Haematology, 1984
- Reporting results of cancer treatmentCancer, 1981
- Cells Capable of Colony Formation in the Peripheral Blood of ManScience, 1971